You just read:

Windtree Announces Successful Completion of Enrollment in AEROSURF® Phase 2b Clinical Trial for the Treatment of Respiratory Distress Syndrome (RDS) in Premature Infants

News provided by

Windtree Therapeutics, Inc.

Jun 01, 2017, 16:05 ET